Two things -
1. Awhile ago they said something about continuing pig studies until they can make it work right in pigs. When they said that it sounded like it wasn't working right in pig studies.
2. It seems like it's been in pig studies quite awhile so it seems like if it was going well in pig...
IMO this device could become the gold standard for injecting cell-based hair loss therapies into the scalp by all companies, not just Replicel. For years I've had concerns about how Stemson and Hairclone and other companies will inject their cell-based treatments into the scalp. I think this...
Epibiotech is in South Korea. If Epibiotech applies for the IND in South Korea maybe the approval process is shorter in South Korea than the US FDA process.
1. What if the area they implanted the cells regrew all the hair that could possibly fit in that area, in which case there would be no point in putting more time into the study because the technique obviously results in full regrowth.
2. Or maybe they were thrilled by the results so they wanted...
But we all already have SCUBE3 in our bodies so if we topically increase SCUBE3 a dab in the scalp it's not like we would be adding something new and totally unpredictable to our bodies. Also, there are newer topical vehicles that can dramatically reduce how much active drug seeps deeper into...
But one thing is that Stemson is planning to put time into trying to figure out a way to protect new Stemson hairs from our androgens. This stuff might be a solution to that problem and a solution to that problem *might* possibly speed up the Stemson timeline to clinical trials. For all we know...
I'm not so sure about that. This looks like interesting info to me.
I wonder if we could easily get our hands on SCUBE3 since it's obviously something that's already in our bodies.
At minimum SCUB3 looks like it *might* be something that *might* protect the hair we get from cell treatments...